OCS
Oculis Holding AG Ordinary shares
NASDAQ: OCS · HEALTHCARE · BIOTECHNOLOGY
$27.48
+3.89% today
Updated 2026-04-30
Market cap
$1.57B
P/E ratio
—
P/S ratio
1,311.54x
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$16 – $31
Volume
0.4M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
6.3
Growth
B6.8
Quality
B2.5
Profitability
F5.0
Valuation
C+1/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$47.50
+72.85%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 13,600.00% QoQ
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-16.02M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $912000.00 | $883000.00 | $686000.00 | $0.00 | $1.20M |
| Net income | $-38.70M | $-88.80M | $-85.78M | $-94.51M | $-23.34M |
| EPS | — | — | — | — | $-2.40 |
| Free cash flow | $-28.62M | $-53.89M | $-47.73M | $-62.51M | $-16.02M |
| Profit margin | -4,243.20% | -10,056.85% | -12,503.94% | — | — |
Peer comparison
Smart narrative
Oculis Holding AG Ordinary shares trades at $27.48. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. TTM revenue stands at $1.20M.
Frequently asked questions
What is Oculis Holding AG Ordinary shares's stock price?
Oculis Holding AG Ordinary shares (OCS) trades at $27.48.
Is Oculis Holding AG Ordinary shares overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell).
What is the price target of Oculis Holding AG Ordinary shares (OCS)?
The analyst target price is $47.50, representing +72.9% upside from the current price of $27.48.
What is Oculis Holding AG Ordinary shares's revenue?
TTM revenue is $1.20M.
Piotroski F-Score?
1/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1,311.54x
ROE-73.50%
Beta0.21
50D MA$27.18
200D MA$21.94
Shares out0.06B
Float0.05B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—